Thalidomide maintenance after autologous HSCT
EFS indicates event-free survival; and ND, no difference.
*This cohort was part of a 1910-patient study examining transplantation and nontransplantation therapies.
†This cohort was part of a 710-patient study examining allogeneic and autologous HSCT.
‡Glucocorticoids were given with thalidomide.
Adapted from McCarthy et al.42
Sign In or Create an Account